The report highlights a fundamental flaw in the process, given the states and territories can and do make budget-driven decisions to prevent the administration of CAR-T and gene therapies funded through the National Health Reform Agreement.
Report highlights the need for change on NHRA-funded therapies
May 9, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Podcast - Episode 2, Series 5
January 30, 2026 - - Podcast -
International HTA Collaboration continues as global pricing pressures evolve
January 29, 2026 - - Latest News -
How an Australian Campaign Is tackling the silent epidemic of heart and kidney disease
January 29, 2026 - - Latest News -
ARCS warns workforce gaps threaten returns on clinical trials reform
January 29, 2026 - - Latest News -
AstraZeneca appoints new country president as Ben McDonald transitions to global role
January 29, 2026 - - Latest News -
Why do some appear so uncomfortable with this group of people getting help?
January 29, 2026 - - Latest News -
New digital health reforms to give Australians a more complete medicines history
January 28, 2026 - - Latest News

